Patterns of T cell clonal expansion in cancer patients associate with response to immunotherapy.

被引：0

作者：

Madireddi, Shravan ^{[1
]}

Wu, Thomas D. ^{[1
]}

de Almeida, Patricia E. ^{[1
]}

Banchereau, Romain ^{[1
]}

Chen, Ying-Jiun J. ^{[1
]}

Chitre, Avantika S. ^{[1
]}

Iftikhar, Hina ^{[1
]}

O'Gorman, William E. ^{[1
]}

Au-Yeung, Amelia ^{[1
]}

Takahashi, Chikara ^{[1
]}

Goldstein, Leonard D. ^{[1
]}

Poon, Chungkee ^{[1
]}

Keerthivasan, Shilpa ^{[1
]}

Mariathasan, Sanjeev ^{[1
]}

Das Thakur, Meghna ^{[1
]}

Huseni, Mahrukh A. ^{[1
]}

Ballinger, Marcus ^{[1
]}

Estay, Ivette ^{[1
]}

Caplazi, Patrick ^{[1
]}

Modrusan, Zora ^{[1
]}

Delamarre, Lelia ^{[1
]}

Mellman, Ira ^{[1
]}

Bourgon, Richard ^{[1
]}

Grogan, Jane L. ^{[1
]}

机构：

[1] Genentech Inc, San Francisco, CA 94080 USA

来源：

CANCER IMMUNOLOGY RESEARCH | 2021年 / 9卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PO084

引用

页数：2

共 50 条

[41] CAR γδ T cells for cancer immunotherapy. Is the field more yellow than green?
Thamizhselvi Ganapathy
Rajalingam Radhakrishnan
Seth Sakshi
Sunil Martin
Cancer Immunology, Immunotherapy, 2023, 72 : 277 - 286
[42] Generation of autologous T cell responses against CLL cells: Implications for immunotherapy.
Krackhardt, A
Trojan, A
Gribben, JG
BLOOD, 1999, 94 (10) : 601A - 601A
[43] Hemato nanotechnology: Artificial APC system for T cell adoptive and active immunotherapy.
De La Pena, H
Madrigal, JA
Bencsik, M
Cave, GWV
Rees, RC
Travers, PJ
Dodi, IA
BLOOD, 2005, 106 (11) : 57B - 57B
[44] Sustained response initiation is required for T cell clonal expansion but not for effector or memory development in vivo
Lefrançois, L
Marzo, A
Williams, K
JOURNAL OF IMMUNOLOGY, 2003, 171 (06): : 2832 - 2839
[45] CLONAL EXPANSION OF T-CELLS - A CYTOTOXIC T-CELL RESPONSE INVIVO THAT INVOLVES PRECURSOR CELL-PROLIFERATION
DENIZOT, F
WILSON, A
BATTYE, F
BERKE, G
SHORTMAN, K
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (16) : 6089 - 6092
[46] Temozolomide in the management of progressive metastatic renal cell cancer (RCC) following immunotherapy.
Özgür, E
Ohlmann, CH
Engelmann, UH
Haupt, G
Heidenreich, A
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 402S - 402S
[47] Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Jiang, Peng
Gu, Shengqing
Pan, Deng
Fu, Jingxin
Sahu, Avinash
Hu, Xihao
Li, Ziyi
Traugh, Nicole
Bu, Xia
Li, Bo
Liu, Jun
Freeman, Gordon J.
Brown, Myles A.
Wucherpfennig, Kai W.
Liu, X. Shirley
NATURE MEDICINE, 2018, 24 (10) : 1550 - +
[48] ICOS Is an Indicator of T-cell-Mediated Response to Cancer Immunotherapy
Xiao, Zunyu
Mayer, Aaron T.
Nobashi, Tomomi W.
Gambhir, Sanjiv S.
CANCER RESEARCH, 2020, 80 (14) : 3023 - 3032
[49] Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang
Shengqing Gu
Deng Pan
Jingxin Fu
Avinash Sahu
Xihao Hu
Ziyi Li
Nicole Traugh
Xia Bu
Bo Li
Jun Liu
Gordon J. Freeman
Myles A. Brown
Kai W. Wucherpfennig
X. Shirley Liu
Nature Medicine, 2018, 24 : 1550 - 1558
[50] Use of prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer receiving immunotherapy.
Yang, Daniel X.
Jairam, Vikram
Park, Henry S.
Decker, Roy H.
Chiang, Anne C.
Gross, Cary Philip
Yu, James B.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

← 1 2 3 4 5 →